RICHMOND, Va. (AP) — The president and chief executive officer of AmpliPhi BioSciences Corp. has resigned.
Richmond-based AmpliPhi says in a news release that Philip J. Young’s departure was effective Sept. 15. The biotechnology company says Young’s resignation was by mutual agreement with its Board of Directors.
Chairman Jeremy Curnock Cook will serve as interim CEO until a replacement is appointed. Wendy Johnson, a member of the board, will serve as interim chief operating officer.
AmpliPhi focuses on developing naturally occurring viruses called bacteriophages to treat infections that often are resistant to existing antibiotic treatments. The company has operations in Richmond, Ljubljana, Slovenia and Sydney, Australia.
